Projects

Ing. Ľudovít Škultéty, DrSc.
Head of Department of Rickettsiology

International

Finished
  • Q fever biomarker discovery using innovative immunoproteomic and metabolomic approaches
    Program: International Visegrad Fund (IVF)
    Duration: 1. 9. 2016 – 31. 8. 2017
  • Development of Lipopolysaccharide-Biopolymer Complex and Conjugates Against the Q Fever Disease For Application Purpose of Vaccine Prototype and Diagnostic Kit
    Program: Inter-academic agreement
    Duration: 1. 12. 2013 – 30. 6. 2017
  • Structural characterisation and anotation of gene cluster of C. burnetii lippoplysaccharide
    Program: Bilateral - other
    Duration: 1. 9. 2015 – 31. 12. 2016
  • Elucidation of tolerance mechanism against flooding in soybean using proteomics technique
    Program: Bilateral - other
    Duration: 1. 4. 2009 – 31. 3. 2011
  • Identification of protein candidates for serodiagnosis of Q fever by immunoproteomic approach
    Program: Bilateral - other
    Duration: 1. 1. 2009 – 31. 12. 2010
  • Array Technologies for BSL3 and BSL4 Pathogens
    Program: COST
    Duration: 27. 5. 2005 – 2. 5. 2010
  • Characterization of Piscirickettsia salmonis infection and technology development for optimal vaccines against intracellular fish pathogens
    Program: Bilateral - other
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Molecular factors and mechanisms of transmission and pathogenicity of highly pathogenic Avian Influenza virus
    Program: FP6
    Duration: 1. 1. 2007 – 31. 12. 2009

National

Current
  • Non-antibiotic approach for the treatment of tick-borne infections
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • The role of metal metabolism in the replication and survival of Coxiella burnetii
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Uncovering the surfaceome and cargo of hepatic extracellular vesicles to identify circulating NAFLD biomarker
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Regulation of Rickettsia and Coxiella transmission via hematophagous arthropods
    Program:
    Duration: 1. 8. 2024 – 30. 6. 2026
Finished
  • Host cell interaction with Coxiella burnetii: identification and utilization of novel therapeutic and diagnostic targets
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Investigation of the Host – Parasite, Cell - Rickettsia Relationship, Monitored by Transcriptomic and Proteome Studies.
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • New insight into the phase variation phenomenon of Coxiella burnetii
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Rickettsiae and Coxiella burnetii, bacterial triggers of the “mysterious“ diseases
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Discovery of clinically relevant proteins and their application in more reliable diagnostics of Q fever
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Activity Assay of Transfer Factor, Immunostimulatory Drug from Leukocytes Extract And Its Preparation Standardization
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Preparation of erythropoietin a therapeutic hormone affecting the production of red blood cells by expression in eukaryotic cell system and its further purification
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Danube meets omics
    Program: SRDA
    Duration: 1. 1. 2017 – 31. 12. 2018
  • Proteomic analyses of the interaction of host with pathogenic bacterium Coxiella burnetii
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Research of biomarkers for diagnosis of rickettsiae, coxiella burnetii and related organisms by state-of-art immunoproteomic and molecular biologic methods.
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • -
    Program: EU Structural Funds Research & Development
    Duration: 1. 3. 2014 – 31. 12. 2015
  • Identification of relevant proteins and characterization of protein-protein interactions of biomarkers of malignant diseases regression
    Program: SRDA
    Duration: 1. 1. 2015 – 31. 12. 2015
  • Understanding of Plant Adaptation in the Radioactive Chernobyl Area
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • -
    Program: EU Structural Funds Research & Development
    Duration: 1. 10. 2011 – 31. 10. 2015
  • Application of magnetic microspheres covalently bound proteolytic enzyme and mass spectrometry on surface-associated protein identification of Coxiella burnetii
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Identification of the cellular proteins affected by persistent infection with lymphocytic choriomeningitis virus
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Comparison of specific markers suitable for detection of rickettsiae, legionellae (Coxiella burnetii), and related intracellular bacteria.
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Identification of the molecular pathways driven by hypoxia-induced carbonic anhydrase IX in tumor cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Development of biopharmaceutics by modern biotechnology
    Program: EU Structural Funds Research & Development
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Centre of Excellence for Translational Research in Molecular medicine
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2010 – 31. 5. 2012
  • Direct detection of Borrelia burgdorferii in Lyme borreliosis patients samples, molecular biological analysis and cross reactivity with selected pathogen species transmitted by ticks
    Program: Other projects
    Duration: 19. 8. 2008 – 31. 12. 2011
  • Center of Excelence for Translational Research in Molecular Medicine
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2009 – 31. 5. 2011
  • Development of the Centre for Molecular Medicine of the Slovak Academy of Sciences as a unique modern clinical research unit in Slovakia
    Program:
    Duration: 1. 8. 2009 – 31. 3. 2011
  • Detection and identification of strain/isolate specific biomarkers of Coxiella burnetii using mass spectrometry
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Molecular-biological characterization of selected tick’s salivary proteins as a potential antigens for development of anti-tick vaccines
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Lipopolysacharides from Coxiella burnetii and Rickettsia typhi. Their chemical composition, structure and function in pathogenesis and immunity of Q fever and endemic typhus
    Program: VEGA
    Duration: 1. 1. 2006 – 31. 12. 2008
  • Mapping and characterization of proteome of Coxiella burnetti, the etiological agent of Q fever
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees